Scaling Up Prevention, Oversight, Reach and Treatment of Tuberculosis in Zimbabwe (SUPPORT-TB) Activity
ID: 355204Type: Posted
Overview

Buyer

Zimbabwe USAID-Harare (USAID-ZIM)

Award Range

$29M - $29M

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/355204
Timeline
    Description

    USAID-Harare is offering a funding opportunity for the "Scaling Up Prevention, Oversight, Reach and Treatment of Tuberculosis in Zimbabwe (SUPPORT-TB) Activity" through a cooperative agreement aimed at improving health outcomes for individuals and communities affected by tuberculosis (TB) in Zimbabwe. The program's objectives include enhancing TB case detection, strengthening case management, preventing new infections, and improving local systems for TB service delivery. This initiative is crucial for addressing the significant challenges in TB treatment and prevention, particularly in light of the ongoing issues with drug-resistant TB. The total funding available for this project is $29 million, with a submission deadline of July 31, 2024. Interested applicants can reach out to Joyce Machingauta at jmachingauta@usaid.gov for further information.

    Point(s) of Contact
    jmachingauta@usaid.gov
    Files
    Title
    Posted
    Amendment.pdf
    The document is an amendment to the Notice of Funding Opportunity (NOFO) No. 72061324RFA00001, issued by USAID for the "Scaling Up Prevention, Oversight, Reach and Treatment of Tuberculosis in Zimbabwe" program. It primarily addresses inquiries received regarding the funding opportunity issued on June 28, 2024. The amendment maintains the original intent and parameters of the NOFO, while providing clarifications on specific questions about eligibility, procurement, and implementation. Key issues addressed include the scope of minor procurements allowed under the grant, expectations for district coverage, roles of international and local partners in consortiums, and the limitations on clinical trials and trial-related activities. Additionally, it underscores the importance of leveraging previous USAID investments and the requirement for organizational performance histories from prime applicants and consortium partners. Other topics include application formatting, evaluation criteria, and eligibility, particularly emphasizing that international partners can collaborate but may not apply as prime applicants. This amendment demonstrates USAID's ongoing support for TB control efforts in Zimbabwe while ensuring transparency and guidance to prospective applicants navigating the funding process.
    Annex1
    Attachment.pdf
    USAID is offering a funding opportunity for local entities through the Notice of Funding Opportunity (NOFO) 72061324RFA00001 to implement the SUPPORT-TB Activity in Zimbabwe, aiming to scale up the prevention, oversight, reach, and treatment of tuberculosis (TB). The deadline for submissions is July 31, 2024. The program addresses significant challenges in TB case detection and treatment, particularly focusing on individuals affected by TB and drug-resistant TB (DR-TB). The activity aligns with Zimbabwe's National Strategic Plan and aims to improve TB outcomes by enhancing case detection, strengthening case management, preventing new infections, and bolstering local systems. Eligible applicants must be Zimbabwean local organizations. The anticipated budget is $29 million over five years, and the project will emphasize integration with other health programs, particularly HIV. Key performance indicators will focus on increasing TB notifications and improving treatment success rates. USAID seeks a collaborative approach with local partners to ensure sustainability and effective service delivery, embracing adaptive management to respond to evolving health needs within Zimbabwe.
    SUPPORT-TB
    Similar Opportunities
    Advancing TB Prevention, Detection and Treatment in the Philippines
    Active
    Philippines USAID-Manila
    USAID/Philippines is forecasting a cooperative agreement opportunity titled "Advancing TB Prevention, Detection and Treatment in the Philippines," aimed at eliminating tuberculosis (TB) in the country. The initiative seeks to partner with capable local organizations, including NGOs, universities, and consortiums, that have experience in infectious disease projects, particularly TB, to contribute to a future five-year project with an estimated funding of $25 million. This project is critical for enhancing health outcomes in the Philippines, addressing a significant public health challenge. Interested organizations can find more information and submission requirements on the USAID/Philippines website or contact Ma. Belinda De La Torre at +63-2-301-4927 or via email at ROAA-Admin-Manila@usaid.gov for further inquiries.
    Supporting the implementation of comprehensive HIV prevention and treatment programs to achieve and sustain epidemic control in Zimbabwe under the President's Emergency Plan for AIDS Relief (PEPFAR)
    Active
    Centers for Disease Control-GHC
    The Centers for Disease Control and Prevention (CDC) is forecasting a federal grant opportunity aimed at supporting the implementation of comprehensive HIV prevention and treatment programs in Zimbabwe under the President's Emergency Plan for AIDS Relief (PEPFAR). The initiative seeks to enhance the capacity of the Zimbabwe Ministry of Health and Child Care to deliver critical HIV services, including differentiated testing, treatment linkage, viral load monitoring, and management of advanced HIV disease, while also addressing non-communicable diseases and TB-HIV collaboration. This funding is vital for improving health outcomes among key populations, particularly children and young women, and will involve collaboration with faith-based and government-supported health facilities. Interested applicants can expect an estimated total funding amount of $10 million for the first year, with applications due by February 17, 2025, and the anticipated award date set for September 30, 2025. For further inquiries, applicants may contact Emily Dale at (404) 639-8880 or via email at pepfarfoas@cdc.gov.
    Support to Zimbabwe's Programs for HIV prevention, Care and Treatment
    Active
    Zimbabwe USAID-Harare
    The United States Agency for International Development (USAID) is forecasting a Request for Information (RFI) to gather insights for future funding opportunities aimed at supporting HIV prevention, care, and treatment programs in Zimbabwe. The RFI seeks to engage local organizations with expertise in HIV program management to provide strategic input for two anticipated Requests for Applications (RFA): Program A, which focuses on enhancing comprehensive health services for HIV-positive individuals and high-risk populations, and Program B, which aims to prevent new infections among adolescent girls and young women through the DREAMS initiative. This initiative is crucial for addressing the multi-sectoral HIV response led by the Government of Zimbabwe. Interested organizations are encouraged to submit their responses, which should include organizational background and program interest, to J. Zeb Simpson at jsimpson@usaid.gov by the specified deadlines. The RFI does not guarantee funding and is intended solely for market research purposes.
    Systems Strengthening for Better HIV/TB Patient Outcomes
    Active
    South Africa USAID-Pretoria
    The South Africa USAID-Pretoria is offering a federal grant opportunity titled "Systems Strengthening for Better HIV/TB Patient Outcomes," aimed at enhancing South African Government systems to improve patient outcomes and prevent HIV through comprehensive clinic-based services. Eligible applicants include local South African non-governmental organizations (NGOs) and for-profit organizations that meet specific criteria, with a focus on addressing all three objectives outlined in the Request for Application (RFA) for optimal evaluation. The program has an estimated total funding of $425 million, with individual awards ranging from $10 million to $150 million, and is expected to result in approximately eight awards. Interested organizations should submit their concept papers and full applications as per the guidelines provided, with inquiries directed to Beatrice Lumande at Applications4@usaid.gov or by phone at +27 12 452 2377.
    Tuberculosis Elimination and Laboratory Cooperative Agreement
    Active
    Centers for Disease Control - NCHHSTP
    The Centers for Disease Control and Prevention (CDC) is offering a cooperative agreement titled "Tuberculosis Elimination and Laboratory Cooperative Agreement" to support tuberculosis (TB) prevention and control activities at state and local levels. The primary objective of this funding is to reduce TB morbidity and mortality by enhancing public health infrastructure for TB disease surveillance, outbreak response, and laboratory testing, with a focus on preventing the transmission of M. tuberculosis and progression from latent TB infection to active disease. This funding is crucial for strengthening public health responses to TB, which remains a significant health threat, particularly in vulnerable populations. The estimated total program funding is $374,456,055, with an expected 57 awards to be made. Applications must be submitted electronically by September 9, 2024, and interested applicants can contact Martha Boisseau at mboisseau@cdc.gov for further information.
    Providing targeted technical assistance to the HIV/TB prevention-care-treatment continuum using cost efficient and scalable quality improvement approaches to address program gaps in support of sustainable HIV services in Zambia under PEPFAR
    Active
    Centers for Disease Control-GHC
    The Centers for Disease Control and Prevention (CDC) is forecasting a federal grant opportunity aimed at providing targeted technical assistance to enhance the HIV/TB prevention-care-treatment continuum in Zambia under the PEPFAR initiative. The objective is to strengthen health systems and improve HIV service delivery by addressing program gaps through cost-efficient and scalable quality improvement approaches, particularly in areas with high unmet needs and sub-optimal coverage. This initiative is critical for achieving the UNAIDS 95-95-95 goals by 2030, as Zambia faces a significant HIV epidemic with a prevalence of 11.1% among adults. Interested applicants can expect an estimated total funding of $15 million for the first fiscal year, with applications due by February 17, 2025. For further inquiries, contact Emily Dale at (404) 639-8880 or via email at pepfarfoas@cdc.gov.
    USAID integrated Delivery of Tuberculosis Service (iDOTS) Activity
    Active
    Nigeria USAID-Abuja
    The Nigeria USAID-Abuja is offering a funding opportunity through the USAID Integrated Delivery of Tuberculosis Service (iDOTS) Activity, aimed at enhancing tuberculosis service delivery in Nigeria. This cooperative agreement seeks to engage local organizations to implement innovative solutions for TB prevention, screening, diagnosis, care, and treatment, while addressing stigma and fostering local ownership of health programs. The initiative is crucial for achieving a healthier population and improving access to quality health services in targeted areas, with a total funding ceiling of $45 million and an expected two awards. Interested applicants must submit their proposals by October 7, 2024, and can direct inquiries to abujasolicitations@usaid.gov for further information.
    Innovative Approaches for TB Prevention and Case Finding to END TB
    Active
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is forecasting a federal grant opportunity titled "Innovative Approaches for TB Prevention and Case Finding to END TB." This initiative aims to develop, implement, and evaluate innovative strategies for tuberculosis (TB) prevention and case finding, focusing on high-burden settings and vulnerable populations, including those living with HIV, children, and economically disadvantaged individuals. The total estimated program funding is $5 million, with an award ceiling of $1 million for up to two cooperative agreements, and applications are expected to be submitted electronically by February 27, 2025. Interested applicants can reach out to Hoang Dang at 404.639.8965 or via email at hdang@cdc.gov for further information.
    TB-HIV Community-Led Monitoring
    Active
    Philippines USAID-Manila
    The Philippines USAID-Manila is offering a federal grant opportunity titled "TB-HIV Community-Led Monitoring," aimed at improving health outcomes for tuberculosis (TB) and HIV/AIDS clients through community-led monitoring activities. The initiative seeks to enhance community leadership, strengthen data collection and analysis platforms, and empower community-based organizations to advocate for health system improvements at both national and local levels. This funding opportunity is restricted to local Philippine organizations, with a total award amount of $2,500,000, and the application deadline is September 10, 2024. Interested applicants can reach out to Aileen Ferrer at manila-roaa-rfa@usaid.gov for further information.
    Tuberculosis Innovations and Health Systems Strengthening in the Philippines
    Active
    Philippines USAID-Manila
    The Philippines USAID-Manila is forecasting a cooperative agreement opportunity titled "Tuberculosis Innovations and Health Systems Strengthening in the Philippines." This initiative aims to engage capable organizations, including NGOs, universities, and for-profit entities, to collaborate with USAID in reducing and eliminating tuberculosis (TB) in the Philippines. The program is critical for enhancing health systems and addressing TB challenges in the region. Interested parties can access the complete Request for Information (RFI) package through the USAID/Philippines website or request a copy via email at manila-roaa-rfp@usaid.gov, with the subject line "RFI-492-17-OH-002." The opportunity is categorized as discretionary funding, with a cost-sharing requirement, and is expected to result in one award. For further inquiries, contact Gracelda M. Laspinas at (632) 3014929.